Spectrawave’s tools are intended to improve PCI treatment and will be integrated into Philips’ Azurion imaging platform.

In patients with diabetes and multivessel coronary artery disease undergoing percutaneous coronary intervention, ticagrelor ...

Enginprime Medical Inc ("Enginprime"), an emerging leader in percutaneous ventricular assist device (pVAD) technologies and a ...

Coronary artery bypass grafting yields better 5-year outcomes in women with chronic severe coronary artery disease than percutaneous coronary intervention, a study finds.

Willis Knighton Health (North) has been designated a Chest Pain Center with Primary PCI Accreditation for the19 th year by the American College of Cardiology. The PCI designation means Willis Knighton ...

Survival, quality of life, and efficacy remained similar in the 3 years after TAVI for patients with versus without blockages ...

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological ...

A recent systematic review and meta-analysis concluded that there is no significant difference in most safety outcomes ...

Alongside a strategy of subintimal tracking and re-entry, bringing patients back for stenting—early or late—offers similar ...

In a bid to tackle medical tourism among Nigerians, the African Medical Centre of Excellence (AMCE) has performed groundbreaking procedures and advanced treatments in the six months since its ...

The Food and Drug Administration (FDA) has granted 510(k) clearance for Vesalio’s enVast clot retriever, paving the way for ...